Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Revenues:      
Royalties $ 88,685 $ 59,423 $ 38,194
Material sales 22,070 22,502 27,662
License fees, milestones and other revenues 30,347 27,048 6,058
Total revenues 141,102 108,973 71,914
Operating costs and expenses:      
Cost of sales [1] 5,366 5,571 5,807
Amortization of intangibles 12,120 10,643 2,375
Research and development 26,887 21,221 11,005
General and administrative 28,653 27,653 25,398
Total operating costs and expenses 73,026 65,088 44,585
Income from operations 68,076 43,885 27,329
Other (expense) income:      
Interest expense, net (11,400) (12,178) (11,802)
Increase in contingent liabilities (2,580) (3,334) (5,013)
Gain on deconsolidation of Viking 0 0 28,190
Loss from Viking (2,048) (23,132) (5,143)
Other income, net 5,183 2,719 1,768
Total other (expense) income, net (10,845) (35,925) 8,000
Income before income tax benefit (expense) 57,231 7,960 35,329
Income tax benefit (expense) (44,675) (10,327) 192,115
Income (loss) from operations 12,556 (2,367) 227,444
Discontinued operations:      
Gain on sale of Oncology Product Line before income taxes 0 1,139 0
Income tax expense on discontinued operations 0 (408) 0
Income from discontinued operations   731 0
Net income (loss) including noncontrolling interests 12,556 (1,636) 227,444
Less: Net loss attributable to noncontrolling interests 0 0 (2,380)
Net income (loss) $ 12,556 $ (1,636) $ 229,824
Basic per share amounts:      
Income (loss) from continuing operations (USD per share) [2] $ 0.60 $ (0.11) $ 11.61
Income from discontinued operations (USD per share) [2]   0.04 0.00
Net income (loss) - Basic (USD per share) [2] 0.60 (0.08) 11.61
Diluted per share amounts:      
Income (loss) from continuing operations (USD per share) [2] 0.53 (0.11) 10.83
Income from discontinued operations (USD per share) [2]   0.04 0.00
Net (loss) income - Diluted (USD per share) [2] $ 0.53 $ (0.08) $ 10.83
Weighted-average shares outstanding - basic (shares) 21,032 20,831 19,790
Weighted-average shares outstanding - diluted (shares) 23,481 20,831 21,228
[1] Excludes amortization of intangibles
[2] The sum of net income per share amounts may not equal the total due to rounding